ZFIN ID: ZDB-PUB-070907-25
Early developmental pathology due to cytochrome c oxidase deficiency is revealed by a new zebrafish model
Baden, K.N., Murray, J., Capaldi, R.A., and Guillemin, K.
Date: 2007
Source: The Journal of biological chemistry   282(48): 34839-34849 (Journal)
Registered Authors: Guillemin, Karen, Murray, Katy
Keywords: none
MeSH Terms:
  • Acridine Orange/pharmacology
  • Animals
  • Apoptosis
  • Cytochrome-c Oxidase Deficiency/genetics*
  • DNA, Mitochondrial/metabolism
  • Electron Transport Complex IV/genetics*
  • Electron Transport Complex IV/physiology*
  • Gene Expression Regulation, Developmental*
  • Heart/embryology
  • Heart/physiology
  • Humans
  • Immunohistochemistry/methods
  • Motor Neurons/metabolism
  • Myocardium/metabolism
  • Neural Tube/embryology*
  • Phenotype
  • Time Factors
  • Zebrafish
PubMed: 17761683 Full text @ J. Biol. Chem.
Deficiency of cytochrome c oxidase (COX) is associated with significant pathology in humans. However, the consequences for organogenesis and early development are not well understood. We have investigated these issues using a zebrafish model. COX deficiency was induced using morpholinos to reduce expression of CoxVa, a structural subunit, and Surf1, an assembly factor, both of which impaired COX assembly. Reduction of COX activity to 50% resulted in developmental defects in endodermal tissue, cardiac function, and swimming behavior. Cellular investigations revealed different underlying mechanisms. Apoptosis was dramatically increased in the hindbrain and neural tube and secondary motor neurons were absent or abnormal, explaining the motility defect. In contrast, the heart lacked apoptotic cells but showed increasingly poor performance over time, consistent with energy deficiency. The zebrafish model has revealed tissue-specific responses to COX deficiency and holds promise for discovery of new therapies to treat mitochondrial diseases in humans.